#LCSM Chat Topic 1/15 at 8PM ET: “Should the FDA Regulate Which Cancer Tests You Can Have?”
The US Food and Drug Administration (FDA) announced its intention to regulate laboratory developed tests. Under the FDA’s proposed Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs) — which treats LDTs as medical devices and healthcare providers as manufacturers — laboratories would have to submit applications for expensive premarket review for thousands of LDTs if they wish to continue offering them to patients. This could limit access to life-saving genomic testing for patients who have cancer and other conditions treatable with targeted drugs. This Thursday, January 15, 2015, at 8 PM… Read More
#LCSM Chat Topic for 12/4 8PM ET: “CMS lung cancer screening rules: overboard, or on the mark?”
The topic for #LCSM Chat on Thursday, December 4, 2014 at 8PM ET will be, “CMS lung cancer screening rules: overboard, or on the mark?” Our moderator Janet Freeman-Daily (@JFreemanDaily) will lead our discussion using the topics below. You can learn more about #LCSM Chat and how to join it here. T1: Do you agree with patient characteristics defined in CMS proposed lung cancer screening coverage? T2: Do you agree there is potential harm in lung cancer screening at centers that don’t have counseling or extensive experience? T3: Will CMS limitations channel… Read More
#LCSM 
You must be logged in to post a comment.